The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family-Reference-Cited by-同舟云学术

The Poorly Membrane Permeable Antipsychotic Drugs Amisulpride and Sulpiride Are Substrates of the Organic Cation Transporters from the SLC22 Family

Published:2014-08-26 Issue:6 Volume:16 Page:1247-1258
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Dos Santos Pereira Joao N.,Tadjerpisheh Sina,Abed Manar Abu,Saadatmand Ali R.,Weksler Babette,Romero Ignacio A.,Couraud Pierre-Olivier,Brockmöller Jürgen,Tzvetkov Mladen V.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-014-9649-9.pdf

Reference54 articles.

1. Strazielle N, Ghersi-Egea JF. Physiology of blood–brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm. 2013;10(5):1473–91.

2. Zamek-Gliszczynski MJ, Hoffmaster KA, Tweedie DJ, Giacomini KM, Hillgren KM. Highlights from the international transporter consortium second workshop. Clin Pharmacol Ther. 2012;92(5):553–6.

3. Benet L, Broccatelli F, Oprea T. BDDCS applied to over 900 drugs. AAPS J. 2011;13(4):519–47.

4. Culot M, Fabulas-da Costa A, Sevin E, Szorath E, Martinsson S, Renftel M, et al. A simple method for assessing free brain/free plasma ratios using an in vitro model of the blood brain barrier. PLoS ONE. 2013;8(12):e80634.

5. Dufour A, De Santi C. Pharmacokinetics and metabolism of amisulpride (In French). Ann Psychiatr. 1988;3:7.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

2. Several orphan solute carriers functionally identified as organic cation transporters: Substrates specificity compared with known cation transporters;Journal of Biological Chemistry;2024-09

3. The eGFR parameter model helps predict blood drug concentration of amisulpride in patients with schizophrenia;2024-08-09

4. Substance Delivery across the Blood-Brain Barrier or the Blood-Retinal Barrier Using Organic Cation Transporter Novel Type 2 (OCTN2);Future Pharmacology;2024-08-04

5. Discovery and Model‐Informed Drug Development of a Controlled‐Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain;Clinical Pharmacology & Therapeutics;2024-05-31